Entocort® Patient Program

In August 2020, Kos designed, developed, and implemented the Entocort® Patient Program through community pharmacies. The Entocort® Program (Program) supports patients prescribed Entocort® (budesonide controlled release) capsules, which is a private prescription-only medicine indicated for the induction of remission in adult patients with mild to moderate Crohn’s disease.